AML-397 Integrated Safety Analysis of Tagraxofusp, a CD123-Directed Targeted Therapy, in Patients With Hematologic Malignancies

Autor: Pammaraju, Naveen 1, Kantarjian, Hagop 1, Sweet, Kendra 2, Wang, Eunice S. 3, Lane, Andrew A. 4, Ali, Haris 5, Stein, Anthony S. 5, Yacoub, Abdulraheem 6, Rizzieri, David 7, Vasu, Sumithira 8, Gupta, Vikas 9, Lee, Sangmin 10, Schiller, Gary J. 11, Foran, James M. 12, Taparia, Minakshi S. 13, Rosenblat, Todd L. 14, Walter, Roland B. 15, Sieminski, Deborah 16, Anant, Madhu 16, Patnaik, Mrinal M. 17, Mughal, Tariq I. 18, 16, Konopleva, Marina 1
Zdroj: In Clinical Lymphoma, Myeloma and Leukemia October 2022 22 Supplement 2:S246-S247
Databáze: ScienceDirect
Externí odkaz: